These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain). Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584 [TBL] [Abstract][Full Text] [Related]
23. How effective are quadruple therapies as first-line H. pylori eradication therapies? Borody TJ Nat Clin Pract Gastroenterol Hepatol; 2005 Apr; 2(4):174-5. PubMed ID: 16265179 [No Abstract] [Full Text] [Related]
24. Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection. de Boer SY; v d Meeberg PC; Siem H; de Boer WA Neth J Med; 2003 Jun; 61(6):218-22. PubMed ID: 12956102 [TBL] [Abstract][Full Text] [Related]
26. One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial. van der Wouden EJ; Thijs JC; van Zwet AA; Kooy A; Kleibeuker JH Am J Gastroenterol; 1998 Aug; 93(8):1228-31. PubMed ID: 9707042 [TBL] [Abstract][Full Text] [Related]
27. A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study. Lerang F; Moum B; Ragnhildstveit E; Haug JB; Hauge T; Tolås P; Aubert E; Henriksen M; Efskind PS; Nicolaysen K; Søberg T; Odegaard A; Berge T Am J Gastroenterol; 1997 Apr; 92(4):653-8. PubMed ID: 9128317 [TBL] [Abstract][Full Text] [Related]
28. Bismuth triple therapy: still a very important drug regimen for curing Helicobacter pylori infection. de Boer WA Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):697-700. PubMed ID: 10445785 [TBL] [Abstract][Full Text] [Related]
30. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy. Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603 [TBL] [Abstract][Full Text] [Related]
32. Tetracycline- and furazolidone-containing quadruple regimen as rescue treatment for Helicobacter pylori infection: a single center retrospective study. Zhang Y; Gao W; Cheng H; Zhang X; Hu F Helicobacter; 2014 Oct; 19(5):382-6. PubMed ID: 24849129 [TBL] [Abstract][Full Text] [Related]
33. Duodenal ulcer disease: to treat H. pylori infection or not? Marshall JB Pharmacoeconomics; 1992 Apr; 1(4):298-9. PubMed ID: 10147111 [No Abstract] [Full Text] [Related]
34. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle]. Lesur G Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500 [No Abstract] [Full Text] [Related]
35. Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection. Yurenev GL; Partzvania-Vinogradova EV; Andreev DN; Dicheva DT; Maiev IV Ter Arkh; 2018 Aug; 90(8):33-39. PubMed ID: 30701937 [TBL] [Abstract][Full Text] [Related]
36. Influence of metronidazole resistance on efficacy of quadruple therapy for Helicobacter pylori eradication. van der Hulst RW; van der Ende A; Homan A; Roorda P; Dankert J; Tytgat GN Gut; 1998 Feb; 42(2):166-9. PubMed ID: 9536938 [TBL] [Abstract][Full Text] [Related]
37. Meta-analysis: the efficacy, adverse events, and adherence related to first-line anti-Helicobacter pylori quadruple therapies. Fischbach LA; van Zanten S; Dickason J Aliment Pharmacol Ther; 2004 Nov; 20(10):1071-82. PubMed ID: 15569109 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori]. López-Brea M; Alarcón T Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820 [No Abstract] [Full Text] [Related]
39. Randomized comparison of two rescue therapies for Helicobacter pylori infection. Wu DC; Hsu PI; Chen A; Lai KH; Tsay FW; Wu CJ; Lo GH; Wu JY; Wu IC; Wang WM; Tseng HH Eur J Clin Invest; 2006 Nov; 36(11):803-9. PubMed ID: 17032348 [TBL] [Abstract][Full Text] [Related]
40. The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea. Chung KH; Lee DH; Jin E; Cho Y; Seo JY; Kim N; Jeong SH; Kim JW; Hwang JH; Shin CM Gut Liver; 2014 Nov; 8(6):605-11. PubMed ID: 25368747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]